T regulatory cells
Showing 1 - 25 of >10,000
Aplastic Anemia Trial in London (Expanded autologous T regulatory cells)
Recruiting
- Aplastic Anemia
- Expanded autologous T regulatory cells
-
London, United KingdomKing's College Hospital
Aug 16, 2022
Abdominal Aortic Aneurysm Trial in Indianapolis (MSCs, Placebo)
Terminated
- Abdominal Aortic Aneurysm
- MSCs
- Placebo
-
Indianapolis, IndianaRichard L. Roudebush VA Medical Center, Indianapolis, IN
Aug 4, 2022
Tregs CD25 CXCL9 in Vitiligo
Not yet recruiting
- Vitiligo
- +3 more
- ELIZA , Flowcytometry
- (no location specified)
Oct 3, 2022
Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)
Completed
- Kidney Failure, Kidney Transplant
- T Regulatory Cell Infusion
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Interleukins in Periodontal Disease Progression
Recruiting
- Periodontitis
- Gingivitis
- Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
-
Assiut, Asyut, EgyptDepartment of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023
GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)
Completed
- Graft Versus Host Disease
- Allogeneic Hematopoietic Cell Transplant Recipient
- Regulatory T Cells
-
Palo Alto, CaliforniaStanford University, School of Medicine
Sep 20, 2021
Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))
Not yet recruiting
- Lymphoma Leukemia
- allogeneic CAR19 regulatory T cells (CAR19-tTreg)
- +2 more
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Dec 6, 2022
GVHD Trial in Tampa (Cultured Treg cells)
Completed
- Graft Versus Host Disease
- Cultured Treg cells
-
Tampa, FloridaH Lee Moffitt Cancer Center
Nov 2, 2022
Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived
Not yet recruiting
- Islet Transplantation
- Infusion of recipient T regulatory cell
- Infusion of concomitant Donor Derived Vertebral Bone Marrow
-
Palo Alto, CaliforniaStanford University
Jul 25, 2023
Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)
Recruiting
- Chronic Graft vs Host Disease
- Regulatory T-cell enriched infusion
-
Sevilla, SpainJosé Antonio Pérez Simón
May 20, 2022
Type1diabetes Trial in Stockholm, Uppsala (Autologous T regulatory cells)
Active, not recruiting
- Type1diabetes
- Autologous T regulatory cells
-
Stockholm, Sweden
- +1 more
Mar 25, 2021
Liver Transplant Rejection Trial in Chicago (Erythropoietin)
Recruiting
- Liver Transplant Rejection
-
Chicago, IllinoisNorthwestern University
Apr 5, 2022
End Stage Renal Disease Trial in Lexington (High Intensity Interval Training)
Not yet recruiting
- End Stage Renal Disease
- High Intensity Interval Training
-
Lexington, KentuckyUniversity of Kentucky Transplant Center
Feb 14, 2022
Autoimmune Diseases, Inflammatory Disease, Acquired Bone Marrow Aplasia Trial (Blood sample taken at a single time point)
Not yet recruiting
- Autoimmune Diseases
- +10 more
- Blood sample taken at a single time point
- (no location specified)
Sep 14, 2022
ALS (Amyotrophic Lateral Sclerosis) Trial in Boston, Houston (Monthly autologous Treg cells infusions + 3 times per week
Active, not recruiting
- ALS (Amyotrophic Lateral Sclerosis)
- Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections
- Monthly placebo infusions + 3 times per week placebo injections
-
Boston, Massachusetts
- +1 more
Sep 29, 2021
Chronic GVHD, Acute GVHD, Steroid Refractory GVHD Trial in Leuven, Liège (Rapamycin, T regulatory cells)
Recruiting
- Chronic Graft-Versus-Host Disease
- +2 more
- Rapamycin
- T regulatory cells
-
Leuven, Vlaams-Brabant, Belgium
- +1 more
Apr 27, 2021
The Significance of Release of T-follicular Helper and
Not yet recruiting
- Autoimmune Hemolytic Anemia
- flowcytometry
- (no location specified)
Oct 22, 2021
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV Trial in Chapel Hill, Columbus (Cryopreserved Ex Vivo
Recruiting
- Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
- Cryopreserved Ex Vivo Expanded Polyclonal CD4+CD127lo/-CD25+ T Regulatory Cells
-
Chapel Hill, North Carolina
- +1 more
Oct 15, 2021
Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- CK0803
- Excipient
-
New York, New YorkColumbia University Irving Medical Center
Jan 26, 2023
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Acute Respiratory Distress Syndrome, Covid19 Trial in Stanford (T regulatory cells)
Withdrawn
- Acute Respiratory Distress Syndrome
- Covid19
- T regulatory cells
-
Stanford, CaliforniaStanford University
Apr 14, 2021
Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory
Recruiting
- Myeloid Leukemia, Chronic
- +8 more
- Conventional T cells (Tcon) and Regulatory T cells (Treg)
-
Palo Alto, CaliforniaStanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021
Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)
Active, not recruiting
- Pemphigus Foliaceus
- Pemphigus Vulgaris
- Cohort 1: 1.0 x 10^8 PolyTregs
- Cohort 2: 2.5x10^8 PolyTregs
-
San Francisco, California
- +3 more
Oct 22, 2021